The cancer anorexia/weight loss syndrome: Exploring associations with single nucleotide polymorphisms (SNPs) of inflammatory cytokines in patients with non-small cell lung cancer

Supportive Care in Cancer

Volumn 18, Issue 10, 2010, Pages 1299-1304

  Jatoi, Aminah ^b   Qi, Yingwei ^a   Kendall, Glenda ^a   Jiang, Ruoxiang ^a   McNallan, Sheila ^a   Cunningham, Julie ^a   Mandrekar, Sumithra ^a   Yang, Ping ^a  

^a MAYO CLINIC   (United States)

^b NONE

Author keywords

Cancer associated anorexia; Non small cell lung cancer; Single nucleotide polymorphism

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR;

ARTICLE; CANCER ANOREXIA WEIGHT LOSS SYNDROME; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; INFLAMMATION; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; QUESTIONNAIRE; SINGLE NUCLEOTIDE POLYMORPHISM; SYNDROME;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANOREXIA; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; INTERLEUKINS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL; SYNDROME; TUMOR NECROSIS FACTOR-ALPHA; WEIGHT LOSS; YOUNG ADULT;

EID: 80053212322     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-009-0748-6     Document Type: Article

References (17)

1. Jeremic B, Milicic B, Dagovic A, Acimovic L, Milisavljevic S (2006) Pretreatment prognostic factors in patients with early stage (I/II) non-small-cell lung cancer treated with hyperfractionated radiation therapy alone. Int J Radiat Oncol Biol Phys 65(4):1112-1119
2. Dewys WD, Begg C, Lavin PT, Band PR, Bennett JM, Bertino JR, Cohen MH, Douglass HO Jr, Engstrom PF, Ezdinli EZ, Horton J, Johnson GJ, Moertel CG, Oken MM, Perlia C, Rosenbaum C, Silverstein MN, Skeel RT, Sponzo RW, Tormey DC (1980) Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med 69(4):491-497
3. Chuang RB, Hu WY, Chiu TY, Chen CY (2004) Prediction of survival in terminal cancer patients in Taiwan: constructing a prognostic scale. J Pain Symptom Manage 28(2):115-122
4. Loprinzi CL, Laurie JA, Wieand HS et al (1994) Prospective evaluation of prognostic variables from patient-completed questionnaires. J Clin Oncol 12:601-7
5. Seruga B, Zhang H, Bernstein LJ, Tannock IF (2008) Cytokines and their relationship to the symptoms and outcome of cancer. Nat Rev Cancer 8(11):887-899
6. Grim-Stieger M, Keilani M, Mader RM, Marosi C, Schmidinger M, Zielinski CC, Fialka-Moser V, Crevenna R (2008) Serum levels of tumour necrosis factor-alpha and interleukin-6 and their correlation with body mass index, weight loss, appetite and survival rate-preliminary data of Viennese outpatients with metastatic cancer during palliative chemotherapy. Eur J Cancer Care 17(5):454-462
7. Bennani-Baiti N, Davis MP (2008) Cytokines and cancer anorexia cachexia syndrome. Am J Hosp Palliat Care 25(5):407-411
8. Zhang D, Zhou Y, Wu L, Wang S, Zheng H, Yu B, Li J (2008) Association of IL-6 gene polymorphisms with cachexia susceptibility and survival time of patients with pancreatic cancer. Ann Clin Lab Sci 38(2):113-119
9. Tan BH, Deans DA, Skipworth RJ, Ross JA, Fearon KC (2008) Biomarkers for cancer cachexia: is there also a genetic component to cachexia? Support Care Cancer 16(3):229-234
10. Zhang D, Zheng H, Zhou Y, Tang X, Yu B, Li J (2007) Association of IL-1beta gene polymorphism with cachexia from locally advanced gastric cancer. BMC Cancer 7:45
11. Rami-Porta R, Crowley JJ, Goldstraw P (2009) The revised TNM stating system for lung cancer. Ann Thorac Cardiovasc Surg 15(1):4-9
12. Bozetti F, Gavazzi C, Micelli R et al (2000) Perioperative total parenteral nutrition in malnourished, gastrointestinal patients. JPEN 24(1):7-14
13. Loprinzi CL, Ellison NM, Schaid DJ, Krook JE, Athmann LM, Dose AM, Mailliard JA, Johnson PS, Ebbert LP, Geeraerts LH (1990) Controlled trial of megestrol acetate for the treatment of cancer anorexia and cachexia. J Natl Cancer Inst 82(13):1127-1132
14. Jatoi A, Egner J, Loprinzi CL et al (2004) Investigating the utility of serum cytokine measurements in a multi-institutional cancer anorexia/weight loss trial. Support Care Cancer 12(9):640-4
15. Dhiman N, Poland GA, Cunningham JM et al (2007) Variations in measles vaccine-specific humoral immunity by polymorphisms in SLAM and CD46 measles virus receptors. J Allerg Clin Immunol 120:666-672
16. Roledo R, Beggs W, Bender P (2003) A simple and effective method for rapid genotyping of insertion/deletion polymorphisms. Genomics 82:580-582
17. Schmidt C (2007) SNPS not living up to promise; experts suggest new approach to disease ID. J National Cancer Institute 99(3):189-9